IN2013MU03428A - - Google Patents

Info

Publication number
IN2013MU03428A
IN2013MU03428A IN3428MU2013A IN2013MU03428A IN 2013MU03428 A IN2013MU03428 A IN 2013MU03428A IN 3428MU2013 A IN3428MU2013 A IN 3428MU2013A IN 2013MU03428 A IN2013MU03428 A IN 2013MU03428A
Authority
IN
India
Prior art keywords
fingolimod
salts
relates
dosage forms
oral dosage
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Venkataramana Naidu
Saurabh Gupta
Prafulla Joshi
Anubhav Nagal
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3428MU2013 priority Critical patent/IN2013MU03428A/en
Publication of IN2013MU03428A publication Critical patent/IN2013MU03428A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3428MU2013 2013-10-30 2013-10-30 IN2013MU03428A (en:Method)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3428MU2013 IN2013MU03428A (en:Method) 2013-10-30 2013-10-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3428MU2013 IN2013MU03428A (en:Method) 2013-10-30 2013-10-30

Publications (1)

Publication Number Publication Date
IN2013MU03428A true IN2013MU03428A (en:Method) 2015-07-17

Family

ID=54397484

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3428MU2013 IN2013MU03428A (en:Method) 2013-10-30 2013-10-30

Country Status (1)

Country Link
IN (1) IN2013MU03428A (en:Method)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3143991A1 (en) * 2015-09-18 2017-03-22 Sanovel Ilac Sanayi ve Ticaret A.S. Fingolimod capsule composition
WO2018178744A1 (en) * 2017-03-29 2018-10-04 Deva Holding Anonim Sirketi Stable formulations of fingolimod

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3143991A1 (en) * 2015-09-18 2017-03-22 Sanovel Ilac Sanayi ve Ticaret A.S. Fingolimod capsule composition
WO2017046345A1 (en) * 2015-09-18 2017-03-23 Sanovel Ilac Sanayi Ve Ticaret A.S. Fingolimod capsule composition
WO2018178744A1 (en) * 2017-03-29 2018-10-04 Deva Holding Anonim Sirketi Stable formulations of fingolimod

Similar Documents

Publication Publication Date Title
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
MX2018007704A (es) Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante.
MX2015010921A (es) Compuestos de carbazol utiles como inhibidores de bromodominio.
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
MX2015016983A (es) Moduladores del transporte nuclear y usos de los mismos.
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
IN2013MU03583A (en:Method)
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
MX2015010829A (es) Compuestos terapeuticos y sus usos.
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX2016003823A (es) Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma.
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
PH12016502322B1 (en) Compounds and methods for preventing or treating malaria
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX373177B (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
IN2013MU03428A (en:Method)
IN2013MU03427A (en:Method)
WO2015200768A3 (en) Pharmacologic treatments of menière's disease